AustralianSuper’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-62,467
| Closed | -$6.32M | – | 293 |
|
|
2023
Q1 | $6.32M | Buy |
+62,467
| New | +$6.32M | 0.04% | 150 |
|
|
2022
Q1 | – | Sell |
-73,792
| Closed | -$6.4K | – | 198 |
|
|
2021
Q4 | $6.4K | Sell |
73,792
-62,037
| -46% | -$5.38K | 0.03% | 176 |
|
|
2021
Q3 | $13M | Sell |
135,829
-71,451
| -34% | -$6.85M | 0.08% | 140 |
|
|
2021
Q2 | $20.2M | Buy |
207,280
+33,076
| +19% | +$3.22M | 0.14% | 98 |
|
|
2021
Q1 | $16.9M | Buy |
174,204
+139,732
| +405% | +$13.6M | 0.13% | 97 |
|
|
2020
Q4 | $3.3M | Buy |
+34,472
| New | +$3.3M | 0.02% | 124 |
|